Progeny 3, Inc. Portfolio

Auto-discovered 13F filer (Top-2000 by latest reported value).

SEC 13F CIK: 0001536006

What is a 13F filing? Who files one and when · What 13F filings can't tell you

MidFocusedHigh Turnover how tags are computed

Q4 2025 · 37 positions · Total reported value $1.86B · Top-10 concentration 61.6% · Updated 2026-10-18

Last updated: 2026-10-18 · Source: SEC EDGAR Form 13F-HR

Turnover: 21.2% · 1 new · 2 cut · 4 exited

Active Share (vs S&P 500): 96.5% · vs QQQ: 96.7% — share of the book that differs from index weights (higher = more active) · ranking

Est. Qtr Return (Q1 2026 → Q2 2026): +3.0% · vs SPY -11.8% · Prev Value $1.87B — last quarter positions weighted by this quarter price moves · ranking

In its Q4 2025 13F filing, Progeny 3, Inc. disclosed 37 equity positions with a combined reported value of $1.86B. The filing implies a focused portfolio: its ten largest positions account for 61.6% of reported value. HoldingsHub classifies the profile as Mid / Focused / High Turnover.

The largest disclosed positions as of Q4 2025 were CCJ ($214.74M), TIC ($153.99M), IBKR ($136.96M). By sector, the heaviest allocations are Consumer Discretionary 20.9%, Financials 15.1%. Versus the prior quarter, allocation shifted toward Industrials (+2.0pp), Other (+1.3pp) and away from Consumer Discretionary (-3.6pp).

Versus the prior quarter, Progeny 3, Inc. opened 1 new positions, trimmed 2 and fully exited 4, a turnover rate of 21.2% of positions. The portfolio's overlap with the prior quarter was 82% of names.

The largest new positions opened in Q4 2025 were SOLS ($35.52M), CRNX ($1.12M), ASND ($1.12M).

Of the 4 positions fully exited versus the prior quarter, the largest were CZR ($50.60M), AGI ($28.36M).

Figures come from the fund's SEC Form 13F filing. 13F reports are filed within 45 days of quarter end and cover long positions of $100,000 or more; they exclude short positions and non-13F asset classes, so treat this page as a quarter-end snapshot rather than the fund's live book.

New Positions (Q4 2025)

  • SOLS SOLSTICE ADVANCED MATLS INC · $35.52M
  • CRNX CRINETICS PHARMACEUTICALS IN · $1.12M
  • ASND ASCENDIS PHARMA A/S · $1.12M
  • PCVX VAXCYTE INC · $1.08M
  • QXO QXO INC · $1.05M

Fully Exited (vs previous quarter)

  • CZR CAESARS ENTERTAINMENT INC NE · prev qtr: $50.60M
  • AGI ALAMOS GOLD INC · prev qtr: $28.36M

Insider Transactions (Form 4)

Latest Progeny 3, Inc. buys and sells reported on SEC Form 4 — filed within two business days when the fund's ownership in a stock crosses 10%.

No Form 4 filings for this fund yet — when its ownership in a stock crosses 10%, buys and sells are filed here within two business days.

Fund Profile

Progeny 3, Inc. is an SEC-registered 13F filer. As of Q2 2026 it reported 29 US equity positions with a combined value of $1.94B. HoldingsHub carries 12 quarters of its filings (Q3 2023–Q2 2026).

Portfolio Structure

  • 29 positions · $1.94B reported value (Q2 2026)
  • Top 10 holdings = 60.6% of reported value
  • Largest position: CCJ (CAMECO CORP F) at 12.4%
  • Average position size: $66.83M

Sector Tilt

  • Consumer Discretionary 26.1%
  • Financials 15.1%
  • Materials 14.7%
  • (classified holdings cover 90% of value)

Quarterly Activity

  • Q2 2026: 1 new, 7 added, 2 reduced, 4 exited
  • 19 positions unchanged

Generated from the firm's public SEC Form 13F and ADV filings. It states what the firm has reported — not an evaluation of its strategy, and not investment advice.

Sector Allocation

Financials 15.1%
Materials 14.2%
Energy 12.1%
Utilities 12.0%
Technology 5.7%
Other 14.3%
Sort by: Value Shares Weight Sector Change · CSV
# Shares Value Weight Allocation Change
1 2.35M $214.74M 11.56%
11.56%
Reduce
2 15.23M $153.99M 8.29%
8.29%
Hold
3 2.13M $136.96M 7.37%
7.37%
Hold
4 3.54M $135.47M 7.29%
7.29%
Hold
5 1.13M $98.39M 5.30%
5.30%
Hold
6 139.07K $95.25M 5.13%
5.13%
Hold
7 2.04M $87.70M 4.72%
4.72%
Add
8 3.28M $76.26M 4.11%
4.11%
Hold
9 2.06M $74.60M 4.02%
4.02%
Add
10 113.15K $70.45M 3.79%
3.79%
Hold
11 103.30K $64.78M 3.49%
3.49%
Hold
12 1.06M $56.52M 3.04%
3.04%
Reduce
13 1.75M $56.02M 3.02%
3.02%
Reduce
14 2.75M $54.30M 2.92%
2.92%
Hold
15 2.48M $53.79M 2.90%
2.90%
Hold
16 971.80K $52.09M 2.80%
2.80%
Add
17 284.93K $48.30M 2.60%
2.60%
Hold
18 2.88M $47.42M 2.55%
2.55%
Add
19 2.22M $45.01M 2.42%
2.42%
Add
20 731.10K $35.52M 1.91%
1.91%
New
21 312.52K $32.63M 1.76%
1.76%
Hold
22 86.50K $32.42M 1.75%
1.75%
Hold
23 229.60K $28.17M 1.52%
1.52%
Hold
24 53.24K $26.76M 1.44%
1.44%
Hold
25 1.27M $24.45M 1.32%
1.32%
Add
26 772.16K $20.33M 1.09%
1.09%
Hold
27 322.30K $14.82M 0.80%
0.80%
Hold
28 54.23K $4.78M 0.26%
0.26%
Hold
29 119.00K $3.07M 0.17%
0.17%
Add
30 103.40K $3.05M 0.16%
0.16%
Add
31 89.16K $2.65M 0.14%
0.14%
Reduce
32 12.24K $1.65M 0.09%
0.09%
Hold
33 128.91K $1.18M 0.06%
0.06%
Add
34 24.00K $1.12M 0.06%
0.06%
New
35 5.23K $1.12M 0.06%
0.06%
New
36 23.30K $1.08M 0.06%
0.06%
New
37 54.50K $1.05M 0.06%
0.06%
New

FAQ

What did Progeny 3, Inc. buy in 2025-Q4?

In its 2025-Q4 13F filing, Progeny 3, Inc. reported 37 equity positions worth $1.86B in aggregate; its largest disclosed positions were CCJ ($214.74M), TIC ($153.99M), IBKR ($136.96M).

How large is Progeny 3, Inc.'s portfolio?

Progeny 3, Inc. reported $1.86B of long equity holdings across 37 positions as of 2025-Q4. Top-10 holdings account for 61.6% of reported value.

What is Progeny 3, Inc.'s investment style?

HoldingsHub classifies the portfolio as Mid / Focused / High Turnover, computed from size, concentration, sector tilt and turnover.

Where does this data come from?

All figures are computed from the fund's SEC Form 13F quarterly filing, which must be filed within 45 days of quarter end for long positions of $100,000 or more.

Embed this fund on your site

Copy the snippet below to show this fund's live top holdings on your blog or forum — free, auto-updating, links back to HoldingsHub.

<iframe src="https://holdingshub.top/funds/progeny-3/widget" width="100%" height="520" frameborder="0" loading="lazy" title="HoldingsHub fund holdings"></iframe>

Preview the embeddable widget →